Bringing a new product to market is a monumental undertaking, requiring substantial investments in research, development, manufacturing, and marketing. However, the most severe threat to a product's success is often not consumer rejection or technical failure, but rather unseen legal landmines. Launching a product without first evaluating the
The pharmaceutical landscape is undergoing a monumental shift. The era of small-molecule blockbusters is giving way to the dominance of biologics—complex, large-molecule drugs derived from living cells. These therapies, ranging from monoclonal antibodies to gene therapies, have revolutionized treatment for conditions like cancer, rheumatoid arthritis, and diabetes.
In today’s fiercely competitive, knowledge-driven global economy, intellectual property (IP) represents one of the most valuable assets a business or individual inventor can possess. Securing a patent grants the holder a legal monopoly—the exclusive right to make, use, sell, or import an invention for a limited period,
